CAR T-Cells for CNS Lymphoma: Driving into New Terrain?

SIMPLE SUMMARY: Primary or secondary central nervous system (CNS) lymphoma is frequently associated with a poor prognosis. CAR T-cells are being established as a relevant treatment approach in hematological B-cell malignancies. Unfortunately, most clinical studies on chimeric antigen-receptor (CAR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Karschnia, Philipp, Blobner, Jens, Teske, Nico, Schöberl, Florian, Fitzinger, Esther, Dreyling, Martin, Tonn, Joerg-Christian, Thon, Niklas, Subklewe, Marion, von Baumgarten, Louisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161128/
https://www.ncbi.nlm.nih.gov/pubmed/34065471
http://dx.doi.org/10.3390/cancers13102503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161128/
https://www.ncbi.nlm.nih.gov/pubmed/34065471
http://dx.doi.org/10.3390/cancers13102503

Ejemplares similares